Research Unit for Functional Genomics, National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Nishi 2-13, Inada, Obihiro, Hokkaido, 080-8555, Japan.
Acta Parasitol. 2022 Dec;67(4):1514-1520. doi: 10.1007/s11686-022-00604-7. Epub 2022 Aug 11.
Malarial parasites are susceptible to oxidative stress. The effects of α-tocopheryloxy acetic acid (α-TEA), a vitamin E analog, on infection by Plasmodium berghei ANKA and P. falciparum in mice and human red blood cells (RBCs), respectively, were examined in this study.
For in vivo studies in mice, RBCs infected with P. berghei ANKA were inoculated via intraperitoneal injection and α-TEA was administered to C57BL/6 J male mice after infection. The blood-brain barrier (BBB) permeability was examined by Evans blue staining in experimental cerebral malaria at 7 days after infection. The in vitro inhibitory effect of α-TEA on P. falciparum 3D7 (chloroquine-sensitive strain) and K1 (multidrug-resistant strain) was tested using a SYBR Green I-based assay.
When 1.5% α-TEA was administered for 14 days after infection, 88% of P. berghei ANKA-infected mice survived during the experimental period. Nevertheless, all the control mice died within 12 days of infection. Furthermore, the Evans blue intensity in α-TEA-treated mice brains was less than that in untreated mice, indicating that α-TEA might inhibit the destruction of the BBB and progression of cerebral malaria. The in vitro experiment revealed that α-TEA inhibited the proliferation of both the 3D7 and K1 strains.
This study showed that α-TEA is effective against murine and human malaria in vivo and in vitro, respectively. Although α-TEA alone has a sufficient antimalarial effect, future research could focus on the structure-activity relationship to achieve better pharmacokinetics and decrease the cytotoxicity and/or the combined effect of α-TEA with existing drugs. In addition, the prophylactic antimalarial activity of premedication with α-TEA may also be an interesting perspective in the future.
疟原虫易受氧化应激的影响。本研究旨在研究 α-生育酚乙酸酯(α-TEA),一种维生素 E 类似物,对感染伯氏疟原虫 ANKA 和恶性疟原虫分别在小鼠和人红细胞(RBC)中的作用。
在体内实验中,用伯氏疟原虫 ANKA 感染的 RBC 通过腹腔注射接种,感染后向 C57BL/6J 雄性小鼠给予 α-TEA。在感染后 7 天,通过 Evans 蓝染色检查实验性脑疟疾的血脑屏障(BBB)通透性。采用 SYBR Green I 基检测法检测 α-TEA 对恶性疟原虫 3D7(氯喹敏感株)和 K1(多药耐药株)的体外抑制作用。
在感染后 14 天给予 1.5%α-TEA 时,88%的感染伯氏疟原虫 ANKA 的小鼠在实验期间存活。然而,所有对照小鼠在感染后 12 天内均死亡。此外,α-TEA 处理的小鼠脑组织中的 Evans 蓝强度低于未处理的小鼠,表明 α-TEA 可能抑制 BBB 的破坏和脑型疟疾的进展。体外实验表明,α-TEA 抑制了 3D7 和 K1 株的增殖。
本研究表明,α-TEA 在体内和体外均有效抗小鼠和人类疟疾。尽管 α-TEA 单独具有足够的抗疟作用,但未来的研究可以集中在构效关系上,以实现更好的药代动力学,降低细胞毒性和/或 α-TEA 与现有药物的联合作用。此外,α-TEA 的预防性抗疟活性也可能是未来的一个有趣的研究方向。